Meeder Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,563
Closed -$23.3K 968
2025
Q1
$23.3K Hold
1,563
﹤0.01% 515
2024
Q4
$23.3K Sell
1,563
-7,280
-82% -$119K ﹤0.01% 496
2024
Q3
$169K Hold
8,843
0.01% 234
2024
Q2
$183K Buy
8,843
+1,563
+21% +$31.1K 0.01% 209
2024
Q1
$137K Sell
7,280
-3,450
-32% -$59.2K 0.01% 318
2023
Q4
$155K Sell
10,730
-393
-4% -$5.35K 0.01% 352
2023
Q3
$193K Buy
11,123
+455
+4% +$9.49K 0.02% 297
2023
Q2
$222K Buy
10,668
+3,073
+40% +$66.8K 0.02% 278
2023
Q1
$179K Sell
7,595
-1,018
-12% -$27.3K 0.01% 345
2022
Q4
$241K Sell
8,613
-1,071
-11% -$27.4K 0.02% 351
2022
Q3
$226K Buy
9,684
+723
+8% +$21.8K 0.01% 551
2022
Q2
$303K Buy
8,961
+61
+0.7% +$2.14K 0.02% 511
2022
Q1
$310K Buy
8,900
+6,365
+251% +$218K 0.02% 552
2021
Q4
$77K Sell
2,535
-14,567
-85% -$474K 0.01% 440
2021
Q3
$561K Buy
17,102
+15,284
+841% +$489K 0.03% 394
2021
Q2
$55K Buy
+1,818
New +$59.8K ﹤0.01% 1085

Other funds holding OGN

Meeder Asset Management's OGN Position: Q2 2025 in Review

Meeder Asset Management sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 1,563 shares — an estimated $23.3K sold.

Meeder Asset Management first reported a position in OGN in Q2 2021 and held it in 16 quarters. The position peaked at $561K in Q3 2021. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Meeder Asset Management reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • Meeder Asset Management sold 1,563 Organon & Co shares in Q2 2025, an estimated $23.3K.
  • Meeder Asset Management first reported a position in Organon & Co in Q2 2021 and held it in 16 quarters.
  • Meeder Asset Management's Organon & Co position peaked at $561K in Q3 2021.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Meeder Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.